Home LiteratureArticle Details
PMID: 16380511 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning.

The Journal of experimental medicine ·Vol. 203 ·No. 1 ·2006-01-23 ·Pages 73-85

Bhattacharya D, Rossi DJ, Bryder D, Weissman IL

Abstract

In the absence of irradiation or other cytoreductive conditioning, endogenous hematopoietic stem cells (HSCs) are thought to fill the unique niches within the bone marrow that allow maintenance of full hematopoietic potential and thus prevent productive engraftment of transplanted donor HSCs. By transplantation of purified exogenous HSCs into unconditioned congenic histocompatible strains of mice, we show that approximately 0.1-1.0% of these HSC niches are available for engraftment at any given point and find no evidence that endogenous HSCs can be displaced from the niches they occupy. We demonstrate that productive engraftment of HSCs within these empty niches is inhibited by host CD4+ T cells that recognize very subtle minor histocompatibility differences. Strikingly, transplantation of purified HSCs into a panel of severe combined immunodeficient (SCID) mice leads to a rapid and complete rescue of lymphoid deficiencies through engraftment of these very rare niches and expansion of donor lymphoid progenitors. We further demonstrate that transient antibody-mediated depletion of CD4+ T cells allows short-term HSC engraftment and regeneration of B cells in a mouse model of B(-) non-SCID. These experiments provide a general mechanism by which transplanted HSCs can correct hematopoietic deficiencies without any host conditioning or with only highly specific and transient lymphoablation.

MeSH Terms
Aging/immunology Animals B-Lymphocytes/immunology CD4-Positive T-Lymphocytes/immunology DNA-Binding Proteins/deficiency,genetics Granulocytes/immunology Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cells/immunology Host vs Graft Reaction Immunologic Surveillance Male Mice Mice, Knockout Mice, SCID Severe Combined Immunodeficiency/immunology,prevention & control T-Lymphocytes/immunology Transplantation Chimera
Chemicals
DNA-Binding Proteins Rag2 protein, mouse
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bhattacharya Deepta
Department of Pathology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. [email protected]
Rossi Derrick J
Bryder David
Weissman Irving L
References (67)
67 references, click to expand
  1. Impaired hematopoietic stem cell functioning after serial transplantation and during normal aging.
    Stem Cells. 2005;23(1):82-92 PMID: 15625125
  2. Gene therapy for severe combined immunodeficiency.
    Annu Rev Med. 2005;56:585-602 PMID: 15660528
  3. Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
    Immunol Rev. 2005 Feb;203:98-109 PMID: 15661024
  4. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.
    Nature. 1990 Apr 19;344(6268):742-6 PMID: 2139497
  5. The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4781-4 PMID: 2352948
  6. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.
    Nature. 1991 Jan 24;349(6307):329-31 PMID: 1987491
  7. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.
    J Exp Med. 1991 May 1;173(5):1213-25 PMID: 1827140
  8. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors.
    Ann Intern Med. 1991 Jun 1;114(11):954-5 PMID: 2024863
  9. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.
    Science. 1991 Sep 20;253(5026):1417-20 PMID: 1910207
  10. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.
    Cell. 1992 Mar 6;68(5):855-67 PMID: 1547487
  11. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
    Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2837-41 PMID: 8464897
  12. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.
    Nature. 2000 Mar 9;404(6774):193-7 PMID: 10724173
  13. Function of cytokines in lymphocyte development.
    Curr Top Microbiol Immunol. 2000;251:59-65 PMID: 11036759
  14. Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation.
    Blood. 2000 Dec 15;96(13):4344-9 PMID: 11110711
  15. Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model.
    Stem Cells. 2001;19(1):80-7 PMID: 11209093
  16. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity.
    Immunity. 2001 Oct;15(4):659-69 PMID: 11672547
  17. Physiological migration of hematopoietic stem and progenitor cells.
    Science. 2001 Nov 30;294(5548):1933-6 PMID: 11729320
  18. Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
    Bone Marrow Transplant. 2002 Jul;30(2):113-8 PMID: 12132050
  19. Little evidence for developmental plasticity of adult hematopoietic stem cells.
    Science. 2002 Sep 27;297(5590):2256-9 PMID: 12215650
  20. A molecular profile of a hematopoietic stem cell niche.
    Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13061-6 PMID: 12226475
  21. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool.
    Immunity. 2002 Oct;17(4):463-72 PMID: 12387740
  22. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99.
    Lancet. 2003 Feb 15;361(9357):553-60 PMID: 12598139
  23. Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies.
    Transplantation. 2003 May 27;75(10):1748-51 PMID: 12777868
  24. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo.
    J Exp Med. 2003 Jul 21;198(2):305-13 PMID: 12874263
  25. Kinetics of steady-state differentiation and mapping of intrathymic-signaling environments by stem cell transplantation in nonirradiated mice.
    J Exp Med. 2003 Sep 15;198(6):957-62 PMID: 12975459
  26. Identification of the haematopoietic stem cell niche and control of the niche size.
    Nature. 2003 Oct 23;425(6960):836-41 PMID: 14574412
  27. Frizzled 9 knock-out mice have abnormal B-cell development.
    Blood. 2005 Mar 15;105(6):2487-94 PMID: 15572594
  28. The role of Notch and IL-7 signaling in early thymocyte proliferation and differentiation.
    Eur J Immunol. 2005 Apr;35(4):1292-300 PMID: 15770699
  29. Cell intrinsic alterations underlie hematopoietic stem cell aging.
    Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9194-9 PMID: 15967997
  30. The relationship between the spleen colony-forming cell and the haemopoietic stem cell.
    Blood Cells. 1978;4(1-2):7-25 PMID: 747780
  31. Relationship between aging and immune system.
    Prog Allergy. 1981;29:134-81 PMID: 7036179
  32. Heterogeneous and monoclonal helper T cells induce similar anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibody populations in the primary adoptive response. I. Isotype distribution.
    Eur J Immunol. 1984 Feb;14(2):188-94 PMID: 6199216
  33. Heterogeneous and monoclonal helper T cells induce similar anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibody populations in the primary adoptive response. II. Lambda light chain dominance and idiotope expression.
    Eur J Immunol. 1984 Feb;14(2):195-200 PMID: 6230245
  34. The total marrow mass of the mouse: a simplified method of measurement.
    Am J Hematol. 1984 Apr;16(3):277-86 PMID: 6711557
  35. Prolonged survival in vivo of unprimed B cells responsive to a T-independent antigen.
    J Exp Med. 1985 Jun 1;161(6):1581-6 PMID: 3874258
  36. Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man.
    Int J Radiat Oncol Biol Phys. 1987 Jul;13(7):1065-9 PMID: 3298176
  37. Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression.
    J Immunol. 1988 May 1;140(9):2970-6 PMID: 3129505
  38. Osteoblastic cells regulate the haematopoietic stem cell niche.
    Nature. 2003 Oct 23;425(6960):841-6 PMID: 14574413
  39. Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis.
    J Exp Med. 2003 Nov 17;198(10):1495-506 PMID: 14610045
  40. Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?
    Exp Hematol. 2003 Dec;31(12):1182-6 PMID: 14662323
  41. Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells.
    Blood. 2004 Apr 1;103(7):2513-21 PMID: 14592820
  42. Regulation of thymus size by competition for stromal niches among early T cell progenitors.
    J Immunol. 2004 Aug 1;173(3):1604-11 PMID: 15265888
  43. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome.
    Lancet. 1968 Dec 28;2(7583):1364-6 PMID: 4177931
  44. Immunological reconstitution of sex-linked lymphopenic immunological deficiency.
    Lancet. 1968 Dec 28;2(7583):1366-9 PMID: 4177932
  45. Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia.
    Blood. 1970 Jun;35(6):741-50 PMID: 4913404
  46. Cells capable of colony formation in the peripheral blood of man.
    Science. 1971 Jan 22;171(3968):293-4 PMID: 5538844
  47. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma.
    Blood. 1978 Jul;52(1):85-95 PMID: 350316
  48. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
    J Immunol. 1993 Dec 1;151(11):6283-90 PMID: 8245467
  49. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
    Blood. 1994 Feb 15;83(4):939-48 PMID: 7906567
  50. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
    J Exp Med. 1994 Nov 1;180(5):1955-60 PMID: 7964471
  51. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.
    Immunity. 1995 Mar;2(3):223-38 PMID: 7697543
  52. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo.
    Immunity. 1995 Sep;3(3):313-9 PMID: 7552996
  53. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    J Immunol. 1995 Dec 15;155(12):5631-6 PMID: 7499847
  54. Lack of B cells precursors in marrow transplant recipients with chronic graft-versus-host disease.
    Am J Hematol. 1996 Jun;52(2):82-9 PMID: 8638646
  55. Critical role for the common cytokine receptor gamma chain in intrathymic and peripheral T cell selection.
    J Exp Med. 1996 Mar 1;183(3):1111-8 PMID: 8642253
  56. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.
    Science. 1996 Jul 12;273(5272):242-5 PMID: 8662508
  57. The aging of hematopoietic stem cells.
    Nat Med. 1996 Sep;2(9):1011-6 PMID: 8782459
  58. Identification of the earliest B lineage stage in mouse bone marrow.
    Immunity. 1996 Dec;5(6):527-35 PMID: 8986713
  59. Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment.
    Exp Hematol. 1997 Feb;25(2):114-21 PMID: 9015211
  60. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Biol Blood Marrow Transplant. 1996 Feb;2(1):3-14 PMID: 9078349
  61. Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation.
    J Rheumatol Suppl. 1997 May;48:23-9 PMID: 9150114
  62. Identification of clonogenic common lymphoid progenitors in mouse bone marrow.
    Cell. 1997 Nov 28;91(5):661-72 PMID: 9393859
  63. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain.
    Br J Haematol. 1998 Nov;103(2):335-42 PMID: 9827902
  64. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    N Engl J Med. 1999 Feb 18;340(7):508-16 PMID: 10021471
  65. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy.
    N Engl J Med. 1957 Sep 12;257(11):491-6 PMID: 13464965
  66. Evidence for stem cells in the peripheral blood of mice.
    Blood. 1962 Jun;19:702-14 PMID: 13900318
  67. CD45 congenic bone marrow transplantation: evidence for T cell-mediated immunity.
    Stem Cells. 2004;22(6):1039-48 PMID: 15536194
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2006-01-23
Epub
2005-00-27
Pages
73-85
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118067
Subset
IM
Grants
NIAID NIH HHS · T32 AI007290 · United States
NIAID NIH HHS · 2R01AI047457 · United States
NHLBI NIH HHS · 5R01HL058770 · United States
NIAID NIH HHS · R01 AI047457 · United States
NHLBI NIH HHS · R01 HL058770 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]